Models
SENORES PHARMACEUTICALS LSENORESPharmaceuticals & Biotechnology
₹364per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹364implied FY26 P/E 12.8× · EV/EBITDA 11.6×
Against CMP ₹1,470.50−75.2%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY31113%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹225₹645
52-week rangetraded range, a fact not a value
₹662₹1,599
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | (247) |
| PV of terminal value | 2,206 |
| Enterprise value | 1,959 |
| less net debt | (282) |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 1,677 |
| ÷ 4.61 crore shares | ₹364 |
113% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 382 | 430 | 487 | 557 | 645 |
| 10.50% | 333 | 373 | 420 | 476 | 545 |
| 11.00% | 292 | 325 | 364 | 410 | 466 |
| 11.50% | 256 | 285 | 317 | 356 | 401 |
| 12.00% | 225 | 250 | 277 | 310 | 347 |
The outlined cell is your model. Green figures sit above the CMP of ₹1,470.50; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | 210 · 354 · 534 |
| Draws below the CMP | 100% |
| Rank correlation with ebitda margin | +0.81 |
| Rank correlation with discount rate | −0.43 |
| Rank correlation with revenue growth | +0.30 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|
| Revenue | 398 | 633 | 822 | 1,069 | 1,390 | 1,807 | 2,349 |
| growth % | — | 58.9 | 30.0 | 30.0 | 30.0 | 30.0 | 30.0 |
| EBITDA | 90 | 168 | 219 | 284 | 370 | 481 | 625 |
| margin % | 22.5 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
| less depreciation | (17) | (31) | (40) | (52) | (68) | (89) | (115) |
| EBIT | 73 | 137 | 178 | 232 | 302 | 392 | 510 |
| less tax on EBIT | (32) | (42) | (55) | (71) | (93) | (120) | |
| NOPAT | 105 | 136 | 177 | 230 | 300 | 389 | |
| add depreciation | 17 | 31 | 40 | 52 | 68 | 89 | 115 |
| less capex | (158) | (240) | (313) | (320) | (305) | (251) | (138) |
| less working-capital build | — | (54) | (70) | (91) | (118) | (154) | |
| Free cash flow to firm | (203) | — | (190) | (161) | (98) | 18 | 212 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||
| Present value | (180) | (138) | (75) | 13 | 133 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 327, dividends at 0% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 137 | 178 | 232 | 302 | 392 | 510 |
| Interest at 7.9% on debt | (26) | (26) | (26) | (26) | (26) | |
| Profit before tax | 153 | 206 | 276 | 366 | 484 | |
| Profit after tax | 0 | 117 | 158 | 211 | 280 | 370 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance sheet, year end | ||||||
| Cash | 46 | (164) | (345) | (462) | (463) | (270) |
| Working capital | 179 | 233 | 303 | 394 | 513 | 667 |
| Net block and other assets | 1,379 | 1,651 | 1,919 | 2,156 | 2,319 | 2,342 |
| Debt | 327 | 327 | 327 | 327 | 327 | 327 |
| Equity | 965 | 1,081 | 1,239 | 1,449 | 1,729 | 2,099 |
| Balance check | 0 | (0) | (0) | (0) | (0) | (0) |
| Cash flow | ||||||
| From operations | 103 | 140 | 188 | 250 | 331 | |
| Investing (capex) | (313) | (320) | (305) | (251) | (138) | |
| Financing (dividends) | 0 | 0 | 0 | 0 | 0 | |
| Net change in cash | (210) | (181) | (117) | (1) | 193 | |
| Free cash flow to equity | (210) | (181) | (117) | (1) | 193 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 30% | 26.6% | 11.00% | 5% | ₹364 | (75.2)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.